Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
DX2LTO
|
||||
| Drug Name |
N-{(S)-1-[2-(4-Methoxy-phenylamino)-ethylcarbamoyl]-3-methyl-butyl}-4-methyl-benzamide
|
||||
| Synonyms |
CHEMBL292472
|
||||
| Indication | Discovery agent | Investigative | [1587926] | ||
| Formula |
C23H31N3O3
|
||||
| Canonical SMILES |
COc1ccc(NCCNC(=O)[C@H](CC(C)C)NC(=O)c2ccc(C)cc2)cc1
|
||||
| InChI |
InChI=1S/C23H31N3O3/c1-16(2)15-21(26-22(27)18-7-5-17(3)6-8-18)23(28)25-14-13-24-19-9-11-20(29-4)12-10-19/h5-12,16,21,24H,13-15H2,1-4H3,(H,25,28)(H,26,27)/t21-/m0/s1
|
||||
| InChIKey |
BMDHIXFGIMLKSR-NRFANRHFSA-N
|
||||
| Target and Pathway | |||||
| Target(s) | Cathepsin K | Target Info | [1587926] | ||
| Cathepsin L | Target Info | [1587926] | |||
| Reactome | Collagen degradation | ||||
| Degradation of the extracellular matrix | |||||
| Activation of Matrix Metalloproteinases | |||||
| Trafficking and processing of endosomal TLR | |||||
| MHC class II antigen presentationR-HSA-1236977:Endosomal/Vacuolar pathway | |||||
| Assembly of collagen fibrils and other multimeric structures | |||||
| MHC class II antigen presentation | |||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.